CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.165
-0.065 (-1.54%)
Nov 21, 2024, 4:00 PM EST - Market closed
CollPlant Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 18.92 | 26.67 | 29.65 | 13.15 | 3.33 | 3.79 | Upgrade
|
| Short-Term Investments | - | - | - | 30.15 | - | - | Upgrade
|
| Cash & Short-Term Investments | 18.92 | 26.67 | 29.65 | 43.3 | 3.33 | 3.79 | Upgrade
|
| Cash Growth | -15.09% | -10.05% | -31.52% | 1199.10% | -12.08% | -29.19% | Upgrade
|
| Accounts Receivable | 0.25 | - | 0.01 | 0.27 | 0.83 | 0.08 | Upgrade
|
| Other Receivables | 0.49 | 0.39 | 0.54 | 0.42 | 0.24 | 0.12 | Upgrade
|
| Receivables | 0.74 | 0.39 | 0.55 | 0.69 | 1.07 | 0.2 | Upgrade
|
| Inventory | 0.44 | 0.71 | 1.43 | 1.08 | 1.26 | 0.89 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.15 | Upgrade
|
| Other Current Assets | 0.24 | 0.24 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Current Assets | 20.34 | 28.02 | 31.66 | 45.09 | 5.68 | 5.04 | Upgrade
|
| Property, Plant & Equipment | 5.96 | 5.86 | 5.68 | 5.68 | 4.9 | 5.54 | Upgrade
|
| Other Intangible Assets | 0.16 | 0.19 | 0.25 | 0.24 | 0.08 | - | Upgrade
|
| Other Long-Term Assets | 0.11 | 0.06 | 0.19 | 0.21 | 0.18 | 0.17 | Upgrade
|
| Total Assets | 26.57 | 34.13 | 37.77 | 51.22 | 10.84 | 10.75 | Upgrade
|
| Accounts Payable | 1.14 | 0.98 | 1.13 | 1.03 | 0.8 | 0.83 | Upgrade
|
| Accrued Expenses | 1.31 | 1.65 | 1.44 | 1.43 | 1.94 | 1.2 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 0.02 | Upgrade
|
| Current Portion of Leases | 0.79 | 0.62 | 0.53 | 0.52 | 0.44 | 0.46 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.03 | 0.21 | 0.94 | Upgrade
|
| Total Current Liabilities | 3.24 | 3.25 | 3.11 | 3.01 | 3.39 | 3.46 | Upgrade
|
| Long-Term Leases | 2.6 | 2.54 | 2.38 | 3.09 | 2.95 | 3.14 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.03 | 0.07 | Upgrade
|
| Total Liabilities | 5.84 | 5.79 | 5.49 | 6.1 | 6.36 | 6.66 | Upgrade
|
| Common Stock | 4.98 | 4.98 | 4.87 | 4.66 | 2.93 | 2.37 | Upgrade
|
| Additional Paid-In Capital | 121.86 | 121.07 | 118.1 | 114.22 | 75.55 | 69.95 | Upgrade
|
| Retained Earnings | -105.15 | -96.74 | -89.72 | -72.8 | -73.03 | -67.26 | Upgrade
|
| Comprehensive Income & Other | -0.97 | -0.97 | -0.97 | -0.97 | -0.97 | -0.97 | Upgrade
|
| Shareholders' Equity | 20.73 | 28.34 | 32.28 | 45.12 | 4.48 | 4.09 | Upgrade
|
| Total Liabilities & Equity | 26.57 | 34.13 | 37.77 | 51.22 | 10.84 | 10.75 | Upgrade
|
| Total Debt | 3.39 | 3.16 | 2.91 | 3.61 | 3.39 | 3.62 | Upgrade
|
| Net Cash (Debt) | 15.54 | 23.52 | 26.74 | 39.69 | -0.06 | 0.17 | Upgrade
|
| Net Cash Growth | -17.96% | -12.07% | -32.62% | - | - | -96.74% | Upgrade
|
| Net Cash Per Share | 1.36 | 2.06 | 2.42 | 3.32 | -0.01 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | 11.45 | 11.45 | 10.77 | 10.77 | 9.91 | 6.46 | Upgrade
|
| Total Common Shares Outstanding | 11.45 | 11.45 | 10.77 | 10.77 | 6.96 | 5.67 | Upgrade
|
| Working Capital | 17.09 | 24.77 | 28.55 | 42.07 | 2.29 | 1.58 | Upgrade
|
| Book Value Per Share | 1.81 | 2.47 | 3.00 | 4.19 | 0.64 | 0.72 | Upgrade
|
| Tangible Book Value | 20.57 | 28.15 | 32.04 | 44.88 | 4.4 | 4.09 | Upgrade
|
| Tangible Book Value Per Share | 1.80 | 2.46 | 2.97 | 4.17 | 0.63 | 0.72 | Upgrade
|
| Machinery | - | 5.33 | 4.7 | 4.11 | 3.15 | 2.88 | Upgrade
|
| Leasehold Improvements | - | 3.5 | 3.31 | 2.63 | 2.43 | 2.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.